About this trial
The purpose of this study is to learn whether Meaning-Centered Psychotherapy (MCP-Dyad) is practical, acceptable, and helpful to survivors and caregivers during recovery after stem cell transplant. MCP-Dyad is a meaning-focused support program. It is designed to help people stay connected to meaning, cope with difficult experiences, and communicate as a pair during recovery.
Eligibility criteria
Qualifiers
Eligible patients and their caregivers must be adults (≥18 years)
Patient must have undergone HSCT for a malignant blood cancer condition
Caregiver must be the main support person (e.g., signed caregiving contract) for the HSCT patient
Both the patient and their caregiver must be willing to participate in the study (dyads only)
Disqualifiers
Patients undergoing HSCT for nonmalignant conditions
Patients and caregivers with severe cognitive or psychiatric impairment that may affect informed consent/participation
Prisoners, pregnant women, and institutionalized persons
Patients with severe cognitive or psychiatric impairment that would affect informed consent or participation
Trial design
Treatments tested in this trial
- Meaning-Centered Psychotherapy
- Usual Care